This initial period represents the dose escalation phase, during which patients typically receive 0.25 mg weekly for the first four weeks before increasing to 0.5 mg
A delicious drink of pure goodness
Eligibility criteria included studies on healthy human subjects, treated for at least 12 weeks with LC administered orally, with no drugs or any other multi-ingredient supplements co-ingestion
Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kushner R, Hunt T et al
All monthly fees include the medication, an initial doctor consultation, and ongoing support, with no separate consult or shipping charges
The total TRIUMPH program has enrolled approximately 5,800 participants, making it one of the largest obesity medication trial programs in history